维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

2篇 您的检索式：作者名="C.Jickling"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Exon expression and alternatively spliced genes in tourette syndrome显示文摘	YingfangTian Isaac H.Liao XinhuaZhan Joan R.Gunther Bradley P.Ander DazhiLiu LisaLit Glen C.Jickling Blythe A.Corbett Netty G.P.Bos‐Veneman Pieter J.Hoekstra Frank R.Sharp	2010	Am J Med Genet2010，，1：	1
	2	Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies显示文摘Background and purpose Detection of atrial fibrillation(AF)after acute ischaemic stroke is pivotal for the timely initiation of anticoagulation to prevent recurrence.Besides heart rhythm monitoring,various blood biomarkers have been suggested as complimentary diagnostic tools for AF.We aimed to summarise data on the performance of cardiac natriuretic peptides for the diagnosis of covert AF after acute ischaemic stroke and to assess their potential clinical utility.Methods We searched PubMed and Embase for prospective studies reporting the performance of B-type natriuretic peptide(BNP)or N-terminal pro-BNP(NT-proBNP)for the diagnosis of covert AF after acute ischaemic stroke.Summary diagnostic performance measures were pooled using bivariate meta-analysis with a random-effect model.Results We included six studies focusing on BNP(n=1930)and three studies focusing on NT-proBNP(n=623).BNP had a sensitivity of 0.83(95% CI 0.64 to 0.93),a specificity of 0.74(0.67 to 0.81),a positive likelihood ratio of 3.2(2.6 to 4.0)and a negative likelihood ratio of 0.23(0.11 to 0.49).NT-proBNP had a sensitivity of 0.91(0.65 to 0.98),a specificity of 0.77(0.52 to 0.91),a positive likelihood ratio of 3.9(1.8 to 8.7)and a negative likelihood ratio of 0.12(0.03 to 0.48).Considering a pretest probability of 20%,BNP and NT-proBNP had post-test probabilities of 45%and 50%.Conclusions NT-proBNP has a better performance than BNP for the diagnosis of covert AF after acute ischaemic stroke.Both biomarkers have low post-test probabilities and may not be used as a stand-alone decision-making tool for the diagnosis of covert AF in patients with acute ischaemic stroke.However,they may be useful for a screening strategy aiming to select patients for long-term monitoring of the heart rhythm.	Kejia Zhang Joseph Kamtchum-Tatuene Mingxi Li Glen C.Jickling	2021	Stroke & Vascular Neurology2021，6，1：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费